Herrin; Brantley R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herrin; Brantley R..The latest application filed is for "variable lymphocyte receptors that target the blood brain barrier and methods of use".

Company Profile

9.6.10

Herrin; Brantley R. - Decatur GA
Herrin; Brantley R. - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant vector and expression system comprising a nucleic acid encoding a variable lymphocyte receptor (VLR) Grant 11,384,134 - Herrin , et al. July 12, 2	2022-07-12
Variable Lymphocyte Receptors That Target The Blood Brain Barrier And Methods Of Use App 20220204583 - Shusta; Eric V. ; et al.	2022-06-30
Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer Grant 11,136,369 - Spencer , et al. October 5, 2	2021-10-05
Methods And Compositions Related To Soluble Monoclonal Variable Lymphocyte Receptors Of Defined Antigen Specificity App 20210253676 - Cooper; Max D. ; et al.	2021-08-19
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity Grant 10,870,692 - Cooper , et al. December 22, 2	2020-12-22
Humanized Variable Lymphocyte Receptors (VLR) and Compositions and Uses Related Thereto App 20200308247 - Herrin; Brantley R. ; et al.	2020-10-01
Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer App 20190256574 - Spencer; H. Trent ; et al.	2019-08-22
Humanized Variable Lymphocyte Receptors (VLR) and Compositions and Uses Related Thereto App 20190202887 - Herrin; Brantley R. ; et al.	2019-07-04
Methods And Compositions Related To Soluble Monoclonal Variable Lymphocyte Receptors Of Defined Antigen Specificity App 20190202897 - Cooper; Max D. ; et al.	2019-07-04
Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer Grant 10,323,077 - Spencer , et al.	2019-06-18
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity Grant 10,239,936 - Cooper , et al.	2019-03-26
Modified recombinant variable lymphocyte receptors (VLR) Grant 10,167,330 - Herrin , et al. J	2019-01-01
Variable Lymphocyte Receptors (VLR) Modifications and Compositions and Uses Related Thereto App 20170081385 - Herrin; Brantley R. ; et al.	2017-03-23
Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer App 20170008947 - Spencer; H. Trent ; et al.	2017-01-12
Methods And Compositions Related To Soluble Monoclonal Variable Lymphocyte Receptors Of Defined Antigen Specificity App 20160376348 - Cooper; Max D. ; et al.	2016-12-29
Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity App 20120189640 - Cooper; Max D. ; et al.	2012-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.